A role of p75 in NGF-mediated down-regulation of the A(2A) adenosine receptors in PC12 cells

Molecular Pharmacology

Volumn 56, Issue 5, 1999, Pages 947-954

  Nie, Zhongzhen ^a   Mei, Yun ^a   Malek, Renae L ^b   Marcuzzi, Adriana ^a   Lee, Norman H ^b   Ramkumar, Vickram ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Institute of Genomics Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

EID: 0032706896     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.5.947     Document Type: Article

References (44)

1. Ambrosini E, Ceccherini-Silberstein F, Erfle V, Aloisi F and Levi G (1999) Gene transfer in astrocytes: comparison between different delivery methods and expression of the HIV-1 protein Nef. J Neurosci Res 55:569-577.
2. Andreopoulos S, Lo PP and Warsh JJ (1995) Developmental expression of G alpha o and G alpha s isoforms in PC12 cells: relationship to neurite outgrowth. Develop Brain Res 88:30-36.
3. 2A receptors upon NGF-induced differentiation of PC12 cells. Neuropharmacology 36:1319-1326
4. Bothwell M (1996) p75NTR: a receptor after all. Science 272:506-507.
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254.
6. Brown AM, Linhoff MW, Stein B, Wright KL, Baldwin AS, Basta PV and Ting JP (1994) Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits. Mol Cell Biol 14:2926-2935.
7. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA and Barde YA (1996) Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science (Wash DC) 272:542-545.
8. Cavallaro S, D'Agata V, Guardabasso V, Travail S, Stivala F and Canonico PL (1995) Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC12 cells. Mol Pharmacol 48:56-62.
9. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
10. 2a adenosine receptor gene. DNA Cell Biol 15:329-337.
11. Dobrowsky RT, Werner MH, Castellino AM, Chao MV and Hannun YA (1994) Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265:1596-1599.
12. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689.
13. Faure M, Voyno-Yasenetskaya TA and Bourne HE (1994) cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269:7851-7854.
14. 2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88:7238-7241.
15. Ferre S, von Euler G, Johansson B and Fredholm B (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51:501-512.
16. Ferre S, Fredholm BB, Morelli M, Popoli P and Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482-487.
17. Greene LA and Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428.
18. Guroff G, Dickens G, End D and Londos C (1981) The action of adenosine analogs on PC12 cells. J Neurochem 37:1431-1439.
19. Hartfield PJ, Bilney AJ and Murray AW J (1998) Neurotrophic factors prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase activation in PC12 cells. J Neurochem 71:161-169.
20. Jiang JH, Cai H, Zhou Q and Levine M (1993) Conversion of a dorsal-dependent silencer into an enhancer: evidence for dorsal corepressors. EMBO J 12:3201-3209.
21. Jumblatt JE and Tischler AS (1982) Regulation of the muscarinic ligand binding sites by nerve growth factor in PC12 phaeochromocytoma cells. Nature (Lond) 297:152-154.
22. Kaplan DR and Miller FD (1997) Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 9:213-221.
23. Lee NH, Weinstock KG, Kirkness EF, Earle-Hughes JA, Fuldner RA, Marmaras S, Glodek A, Gocayne JD, Fraser CM and Venter JC (1995) Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proc Natl Acad Sci USA 92:8303-8307.
24. Lee NH and Malek R (1998) Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity. J Biol Chem 273:22317-22325.
25. Lernbecher T, Muller U and Wirth T (1993) Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (Lond) 365:767-770.
26. 2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173:1169-1178.
27. 2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 286:1051-1057.
28. 2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. Mol Pharmacol 39:130-135.
29. 2 adenosine receptors. FASEB J 9:A123.
30. 1 adenosine receptor expression by activating nuclear factor kappa B. Mol Pharmacol 53:663-669.
31. 2 receptor in PC12 cells. Life Sci 39:1059-1067.
32. Ohmichi M, Pang L, Ribon V, Gazit A, Levitzki A and Saltiel AR (1993) The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor. Biochemistry 32:4650-4658.
33. 2 adenosine receptors by two antipeptide antibody preparations. Mol Pharmacol 42:391-397.
34. 2a adenosine receptor. Mol Pharmacol 48:970-974.
35. Post GR and Brown JH (1996) G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 10:741-749.
36. 1 MF-2 smooth muscle cells. Mol Pharmacol 37:149-156.
37. Song CS, Jung MH, Supakar PC, Chen S, Vellanoweth RL, Chatterjee B and Roy AK (1995) Regulation of androgen action by receptor gene inhibition. Ann New York Acad Sci 761:97-108.
38. Sun S-C, Maggirwar SB and Harhaj E (1995) Activation of NFkB by phosphatase inhibitors involves the phosphorylation of IkBα at phosphatase 2A-sensitive sites. J Biol Chem 270:18347-18351.
39. Tucker AL and Linden J (1993) Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res 27:62-67.
40. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappa-B. Science (Wash DC) 274:787-789.
41. van Biesen T, Hawes BE, Lutrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, Luttrell LM and Lefkowitz RJ (1995) Receptor-tyrosine-kinase and G βγ-mediated MAP kinase activation by a common signaling pathway. Nature 376:781-784.
42. Wiesner DA and Dawson G (1996) Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J Neurochem 66: 1418-1425.
43. Wood JN (1995) Regulation of NF-kappa B activity in rat dorsal root ganglia and PC 12 cells by tumour necrosis factor and nerve growth factor. Neurosci Lett 192:41-44.
44. Zubiaur M and Neer EJ (1993) Nerve growth factor changes G protein level and localization in PC12 cells. J Neurosci Res 36:207-217.